Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

St. John's wort skin oil may increase skin damage risk during radiotherapy.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Men with baldness are more prone to skin cancers on the scalp due to sun exposure, not testosterone.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Cosmetics can contain harmful chemicals that may cause health issues.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Lack of functional CYLD in mice leads to early aging and cancer.

Higher DHT in male baldness may protect against prostate cancer.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Acitretin effectively prevented skin cancer in a patient with late-onset Rothmund-Thomson syndrome.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.